342 related articles for article (PubMed ID: 27502068)
1. Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study.
Li R; Gong F; Zhu Y; Fang W; Yang J; Liu J; Hu L; Yang D; Liang X; Qiao J
Reprod Biomed Online; 2016 Oct; 33(4):506-512. PubMed ID: 27502068
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Anti-Müllerian Hormone and
Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
[TBL] [Abstract][Full Text] [Related]
3. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
5. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study.
Papaleo E; Zaffagnini S; Munaretto M; Vanni VS; Rebonato G; Grisendi V; Di Paola R; La Marca A
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():94-99. PubMed ID: 27835829
[TBL] [Abstract][Full Text] [Related]
9. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
10. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.
Hamdine O; Eijkemans MJC; Lentjes EGW; Torrance HL; Macklon NS; Fauser BCJM; Broekmans FJ
Fertil Steril; 2015 Oct; 104(4):891-898.e2. PubMed ID: 26196233
[TBL] [Abstract][Full Text] [Related]
11. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
[TBL] [Abstract][Full Text] [Related]
12. The significance of serum anti-Müllerian hormone (AMH) levels in patients over age 40 in first IVF treatment.
Tokura Y; Yoshino O; Ogura-Nose S; Motoyama H; Harada M; Osuga Y; Shimizu Y; Ohara M; Yorimitsu T; Nishii O; Kozuma S; Kawamura T
J Assist Reprod Genet; 2013 Jun; 30(6):821-5. PubMed ID: 23640374
[TBL] [Abstract][Full Text] [Related]
13. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Arce JC; Andersen AN; Fernández-Sánchez M; Visnova H; Bosch E; García-Velasco JA; Barri P; de Sutter P; Klein BM; Fauser BC
Fertil Steril; 2014 Dec; 102(6):1633-40.e5. PubMed ID: 25256937
[TBL] [Abstract][Full Text] [Related]
14. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.
Lin PY; Huang FJ; Kung FT; Chiang HJ; Lin YJ; Lin YC; Lan KC
Int J Clin Exp Pathol; 2014; 7(9):6245-53. PubMed ID: 25337276
[TBL] [Abstract][Full Text] [Related]
16. Basal serum anti-Mullerian hormone (AMH) is a promising test in prediction of occurrence of pregnancy rate in infertile women undergoing ICSI cycles.
Kamel HM; Amin AH; Al-Adawy AR
Clin Lab; 2014; 60(10):1717-23. PubMed ID: 25651719
[TBL] [Abstract][Full Text] [Related]
17. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
[TBL] [Abstract][Full Text] [Related]
18. Age-specific reference values and cut-off points for anti-müllerian hormone in infertile women following a long agonist treatment protocol for IVF.
Heidar Z; Bakhtiyari M; Foroozanfard F; Mirzamoradi M
J Endocrinol Invest; 2018 Jul; 41(7):773-780. PubMed ID: 29235049
[TBL] [Abstract][Full Text] [Related]
19. Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes.
Ashrafi M; Hemat M; Arabipoor A; Salman Yazdi R; Bahman-Abadi A; Cheraghi R
J Obstet Gynaecol; 2017 Jan; 37(1):82-88. PubMed ID: 27976974
[TBL] [Abstract][Full Text] [Related]
20. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
